Steps forward in regulatory pathways for acute and chronic heart failure-Reference-Cited by-同舟云学术

Steps forward in regulatory pathways for acute and chronic heart failure

Published:2014-12 Issue:2 Volume:1 Page:87-93
ISSN:2055-5822
Container-title:ESC Heart Failure
language:en
Short-container-title:ESC Heart Failure

Author:

Pani Luca¹,Pecorelli Sergio¹,Rosano Giuseppe¹²³,Anker Stefan D.⁴,Peracino Andrea⁵,Fregonese Laura⁶,Prasad Krishna⁷⁸,Rasi Guido⁶⁹

Affiliation:

1. Italian Medicines Agency—AIFA Rome Italy

2. Cardiovascular and Cell Sciences Research Institute St George's University London UK

3. IRCCS San Raffaele Rome Italy

4. Department of Innovative Clinical Trials University Medical Centre Göttingen Göttingen Germany

5. Fondazione Giovanni Lorenzini Medical Science Foundation Milan Italy Houston USA

6. European Medicines Agency—EMA London UK

7. Medicines and Healthcare Products Regulatory Agency—MHRA London UK

8. St Thomas' Hospital London UK

9. Department of Experimental Medicine and Surgery, School of Medicine and Surgery University of Tor Vergata Rome Italy

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ehf2.12015

Reference19 articles.

1. Acute Heart Failure Syndromes

2. Novel therapeutic targets for the treatment of heart failure

3. What are the costs of heart failure?

4. Progress or lack of progress in hospitalized heart failure

5. Note for Guidance on Clinical Investigation of Medicinal Products for the Treatment of Cardiac Failure. Addendum on Acute Cardiac Failure (CPMP/EWP/2986/03).http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003338.pdf(July 29 2004).

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ESC Heart Failure:a new journal aims to broaden heart failure views;European Journal of Heart Failure;2016-12

2. The appropriate dose of angiotensin‐converting‐enzyme inhibitors or angiotensin receptor blockers in patients with dilated cardiomyopathy. The higher, the better?;ESC Heart Failure;2015-11-17

3. The EJHF last Editor's legacy: how can a high impact factor be built?;ESC Heart Failure;2015-04-29